Ferring Pharmaceuticals: Infertility trials

The registry lists 45 Infertility studies with Ferring Pharmaceuticals as lead sponsor. 0 are open to participants now and 19 have results posted.

Phase 1 4Phase 2 7Phase 3 13Phase 4 6No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian StimulationCompletedNCT05263388Phase 3Results posted
• Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)CompletedNCT04163458Phase 3Results posted
• Rekovelle PK Trial in Chinese WomenCompletedNCT04150861Phase 1Results posted
• Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)CompletedNCT03809429Phase 3Results posted
• Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)CompletedNCT03740737Phase 3Results posted
• Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)CompletedNCT03738618Phase 3Results posted
• Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese WomenCompletedNCT03228680Phase 3Results posted
• MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject PopulationCompletedNCT02554279Phase 4Results posted
• A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian StimulationCompletedNCT02449889Phase 3Results posted
• Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2CompletedNCT01956123Phase 3Results posted
• Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1CompletedNCT01956110Phase 3Results posted
• A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI TreatmentCompletedNCT01426386Phase 2Results posted
• Menopur Mixed ProtocolCompletedNCT01417195Phase 4Results posted
• Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)CompletedNCT01225835Phase 4Results posted
• MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo TransferCompletedNCT00884221Phase 3Results posted
• Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)CompletedNCT00805935Phase 4Results posted
• MENOPUR® Versus FOLLISTIM®CompletedNCT00802360Phase 4Results posted
• Exploratory Study Assessing Synchronisation of Egg Sacs With DegarelixCompletedNCT00434122Phase 2Results posted
• A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin AlfaCompletedNCT00257556Phase 4Results posted
• A Study to Measure Pharmacokinetic (PK) Concentrations of Gonadotropin-Releasing Hormone Delivered by the OmniPod PumpWithdrawnNCT07152730Phase 1
• To Investigate REKOVELLE in Chinese Women Undergoing Assisted Reproductive Technologies: Effectiveness, Safety, and Patterns of Use in Real-world PracticeActive, not recruitingNCT07029451
• Prospective, Multi-centre, Non-Interventional Study to Investigate the Effectiveness of REKOVELLE® for Ovarian Stimulation for Asian Women in Real World SettingsActive, not recruitingNCT06561958
• REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)CompletedNCT06545877
• An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.TerminatedNCT06511791Phase 1
• Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian StimulationWithdrawnNCT05571111Phase 2
• A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy WomenCompletedNCT04902131Phase 1
• MEDAM (Menopur Retrospective Data prograM)CompletedNCT04876300
• Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility TreatmentWithdrawnNCT04814940
• Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian WomenCompletedNCT04773353Phase 3
• Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)CompletedNCT04654039
• A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®CompletedNCT02935335
• A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With InfertilityCompletedNCT02835469
• A Dose-response Trial Using FE 999049 in Japanese Women Undergoing in Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) TreatmentCompletedNCT02309671Phase 2
• An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human EmbryosCompletedNCT02018159
• Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) ProgramCompletedNCT01922193Phase 3
• Barusiban Subcutaneously for Reducing Implantation Failure Due to Uterine ContractionsCompletedNCT01723982Phase 2
• Study of the Cleavage of the Egg in Relation to the Stimulation TreatmentCompletedNCT01674894
• Assessment of the Effectiveness of Menopur in Intrauterine InseminationCompletedNCT01354834
• Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH AntagonistCompletedNCT01331733
• Assessment of the Effectiveness and Tolerability of Ovarian HyperstimulationCompletedNCT01331720
• Assessment of the Therapeutic Utility of hMG-HPCompletedNCT01330784
• Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HPCompletedNCT01330771
• Post Marketing Surveillance of MENOPURCompletedNCT01202123
• Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile FemalesCompletedNCT00796289Phase 2
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRHCompletedNCT00296465Phase 2/3